PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Penfluridol→

Penfluridol PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
26864-56-2
Molecular formula
C28H27ClF5NO
Molecular weight
523.97 g/mol
Drug class
Long-acting diphenylbutylpiperidine antipsychoticdopamine D2 receptor antagonist
Mechanism of action
Blocks central dopamine D2 receptors, reducing dopaminergic neurotransmission in pathways associated with psychotic symptoms. Its long duration of action supports intermittent oral dosing.
Indications / reported uses
  • Maintenance or long-term treatment of schizophrenia and other psychotic disorders where penfluridol remains authorised.

Sources: https://meshb.nlm.nih.gov/record/ui?ui=D010395 · https://www.ncbi.nlm.nih.gov/mesh/68010395

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Penfluridol PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Penfluridol Permitted Daily Exposure (PDE) report (the Penfluridol PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Penfluridol Occupational Exposure Limit (OEL) report (the Penfluridol OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.